FindTrial
Sign In

Impact of hydroxychloroquine dosage on visual function in individuals with rheumatoid arthritis

Association of hydroxychloroquine dosage on visual function among individuals with rheumatoid arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071173
Enrollment
80
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H538- Other visual disturbances

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Thondavada Lalitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group >18 years old 2.Both males and females 3.Individuals diagnosed with rheumatoid arthritis under hydroxychloroquine dosage

Exclusion criteria

Exclusion criteria: 1.Any systemic disease other than rheumatoid arthritis 2.History of contact lens usage & computer use of more than 6 hours 3.Patients with a history of ocular injury or intra-ocular surgery

Design outcomes

Primary

MeasureTime frame
Visual acuity, contrast sensitivity, color vision, stereo acuity, photo stress testTimepoint: One time measurement—

Secondary

MeasureTime frame
Tear film quality , Intraocular pressure and Structural changesTimepoint: One time measurement—

Countries

India

Contacts

Public ContactThondavada Lalitha

Manipal College of Health Professions

preethi.naik@manipal.edu8105619834

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026